News|Articles|October 31, 2024
Pharmatech Insights – Developing a Biosimilar Candidate
Author(s)Pharmatech
A key element of a biosimilar program includes building a development plan to demonstrate comparability between the proposed product and the selected reference product. What steps should be taken to prepare?
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
2
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
3
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
4
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
5